Jazz Pharmaceuticals (JAZZ) Long-Term Investments (2016 - 2025)
Jazz Pharmaceuticals has reported Long-Term Investments over the past 11 years, most recently at $1.0 billion for Q4 2025.
- Quarterly Long-Term Investments rose 81.03% to $1.0 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.0 billion through Dec 2025, up 81.03% year-over-year, with the annual reading at $1.0 billion for FY2025, 81.03% up from the prior year.
- Long-Term Investments was $1.0 billion for Q4 2025 at Jazz Pharmaceuticals, up from $720.0 million in the prior quarter.
- Over five years, Long-Term Investments peaked at $1.0 billion in Q4 2025 and troughed at $60.0 million in Q2 2022.
- The 5-year median for Long-Term Investments is $387.5 million (2024), against an average of $417.5 million.
- Biggest five-year swings in Long-Term Investments: skyrocketed 681.25% in 2024 and later dropped 23.2% in 2025.
- Tracing JAZZ's Long-Term Investments over 5 years: stood at $335.0 million in 2021, then tumbled by 82.09% to $60.0 million in 2022, then soared by 100.0% to $120.0 million in 2023, then surged by 383.33% to $580.0 million in 2024, then soared by 81.03% to $1.0 billion in 2025.
- According to Business Quant data, Long-Term Investments over the past three periods came in at $1.0 billion, $720.0 million, and $480.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.